Carpmaels & Ransford name two new partners
Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.
Chris Hoggett focuses his practice on pharmaceuticals and cases relating to new chemical formulations. Hogget has successfully defended patents for a number of blockbuster drugs including as lead counsel in proceedings at the European Patent Office (EPO) on behalf of Gilead and Novartis.
Stephen Duffield specialises his practice on biological therapies, having represented companies such as Janssen Biotech and Regeneron. He has worked on both offensive and defensive patent litigation at the EPO, including oppositions and appeals.
Richard Jackson, managing partner at Carpmaels & Ransford, said that the appointments would “further strengthen our life sciences capability and demonstrate our commitment to supporting and promoting talent in the firm”.
Both Hoggett and Duffield joined the firm as trainees.
Did you enjoy reading this story? Sign up to our free newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk